GRI: gribio.com Short-Term Debt to Equity
This chart of the short-term debt-to-equity ratio for GRI Bio, Inc. (GRI) shows 0.00, driven by management's bet on breakthrough NKT-cell therapies. GRI Bio, Inc. (GRI) is actively developing modulators to combat lung and liver inflammation during early response stages. The business focuses on creating immunotherapies for individuals with chronic pathologies, targeting a vast global market for specialized biotechnology.
Analytical breakdowns for GRI Bio, Inc.
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
General company analysis:GRI Bio Corp GRI
When selecting assets with a high margin of safety, it is critical to analyze the ratio of short-term liabilities to equity, which measures the risk of shareholder value dilution due to operational loans. For GRI Bio, Inc., which relies on grants during the clinical development of immune drugs, the current level of short-term debt relative to equity serves as an indicator of the balance between financial stability and the pace of business growth.
Competing companies
Short-Term Debt to Capital ARGX|Short-Term Debt to Capital BNTX (BioNTech Pharma)|Short-Term Debt to Equity Abivax Pharma|admabiologics.com - Ratio of Short-Term Indebtedness to Capital|PTGX: Short-Term Debt to Equity|IMVT - Short-Term Debt to Equity Ratio|KNSA: Short-Term Debt to Capital|Short-Term Debt to Capital Grifols Biemat|ADPT - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital celldex.com|AUPH (Aurinia Pharmaceuticals Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma - Short-Term Debt to Equity|Dianthus Corp - Short-Term Debt to Equity Ratio|PHVS: Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|TRML: Short-Term Debt to Equity Ratio|PGEN (Precigen Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Pharming (PHAR)|Short-Term Debt to Capital Ratio Nektar Corp|Upstream Bio Inc - Short-Term Debt to Capital|Current Liabilities to Capital zenasbio.com (ZBIO)|IMNM (Immunome) - Short-Term Debt to Capital|Gossamer Bio Inc - Short-Term Indebtedness to Equity|Short-Term Debt to Equity KalVista Pharmaceuticals Inc (KALV)|SEPN - Ratio of Short-Term Indebtedness to Capital|Pieris Pharmaceuticals - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient savarapharma.com|RIGL - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AnaptysBio Inc|Short-Term Debt to Capital Astria Pharma (ATXS)|Short-Term Debt to Equity enGene Corp (ENGN)|Short-Term Debt to Capital RAPT|Aerovate Therapeutics, Inc. - Short-Term Debt to Capital Coefficient|ACRS (Aclaris Therapeutics, Inc.) - Short-Term Debt to Equity|Kyverna Therapeutics Inc. (KYTX) - Current Liabilities to Capital|Short-Term Debt to Equity Ratio Tiziana Life Sciences PLC TLSA|Cabaletta Bio Inc (CABA) - Ratio of Short-Term Indebtedness to Capital|VTYX: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient THTX|Short-Term Debt to Equity Avalo Therapeutics AVTX|Short-Term Debt to Capital Ratio Eledon Pharmaceuticals Inc. (ELDN)|Agenus Inc - Short-Term Debt to Capital|CLYM - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio ZURA (Zura Bio)|ATYR - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital ADAG (adagene.com)|IMA (Ikena Oncology) - Short-Term Indebtedness to Equity|STTK - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Equillium Bio|CNTB (Connect Biopharma) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient IMUX (immunic-therapeutics.com)|Atara Bio (ATRA) - Short-Term Debt to Equity|Current Liabilities to Equity InflaRx NV IFRX|Short-Term Debt to Capital X4 Pharma (XFOR)|ACET - Ratio of Short-Term Indebtedness to Capital|CELU: Short-Term Debt to Capital|INMB (inmunebio.com) - Short-Term Debt to Capital|BRNS - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital KZR|Short-Term Debt to Equity SABS (SAB Biotherapeutics, Inc)|Short-Term Debt to Equity Ratio Akari Therapeutics, Plc (AKTX)|Short-Term Debt to Capital ENLV (Enlivex Therapeutics Ltd.)|QTTB - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio GeoVax (GOVX)|EDSA - Ratio of Short-Term Indebtedness to Capital|iBio Corp - Short-Term Debt to Capital|CARM (Carisma Therapeutics Inc.) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity XTLB|Short-Term Debt to Equity Ratio BOLT|Short-Term Debt to Equity HCWB (HCW Biologics Inc.)|Short-Term Debt to Equity Ratio aptevotherapeutics.com APVO|Short-Term Debt to Equity Ratio AIM (AIM ImmunoTech Inc.)|Aditxt Inc. - Short-Term Debt to Capital|XORTX Therapeutics Inc. (XRTX) - Short-Term Debt to Equity|HIND - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital REVB|Indaptus Therapeutics Inc (INDP) - Current Liabilities to Capital|Scinai - Short-Term Debt to Capital|Short-Term Indebtedness to Equity CALI|Affimed (AFMD) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital allakos.com (ALLK)|Short-Term Debt to Capital HOOK|IGMS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio iTeos (ITOS)|OCEA - Ratio of Short-Term Indebtedness to Capital|TC Biopharm (TCBP) - Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Equity